Comparable stake leader
Robert W. Duggan
SEC ownership of PULSE BIOSCIENCES, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001625101.
Disclosed value leader
Robert W. Duggan
Comparable rows
50/50
Latest evidence
11 Jun 2026
- Public ticker
- PLSE on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Robert W. Duggan
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Robert W. Duggan
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
11 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001625101
- Issuer location
- Hayward, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of PULSE BIOSCIENCES, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Robert W. Duggan
Disclosed value leader
Robert W. Duggan
Comparable rows
50/50
Latest evidence
11 Jun 2026
3/4/5
13D/G
13F
Lead comparable stake: 72%
13D/G row: Robert W. Duggan
Showing 1-8 of 50 holder rows.
Quick read
Robert W. Duggan leads the comparable SEC ownership view at 72%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Robert W. Duggan's linked filing trail.
Comparable ownership
Top 5
Robert W. Duggan
72%
BlackRock, Inc.
1.9%
BANK OF AMERICA CORP /DE/
1.3%
VANGUARD CAPITAL MANAGEMENT LLC
1.2%
Portolan Capital Management, LLC
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Robert W. Duggan |
3/4/5
13D/G
Director, 10%+ Owner
|
72%
from 13D/G
|
$975,729,858
49,462,840 shares
mixed-class rows
|
+$13,508,089 | 11 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
1.9%
|
$28,925,807
1,339,778 shares
|
— | 31 Mar 2026 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
1.3%
|
$18,698,257
866,061 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
1.2%
|
$17,614,245
815,852 shares
|
— | 31 Mar 2026 |
| Portolan Capital Management, LLC |
13F
Company
|
1.1%
|
$15,833,501
733,372 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.71%
|
$10,623,020
491,946 shares
|
— | 31 Mar 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
Company
|
0.67%
|
$9,993,989
462,899 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13F
Company
|
0.66%
|
$9,865,054
456,927 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$8,555,859.
Buys
$13,803,439
Insiders: 2
Sells
$5,247,580
Insiders: 2
Net
+$8,555,859
Shares: +439,892
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 709,892
Shares: 270,000
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 675,233 | 0 | $13,295,338 | $0 | +$13,295,338 |
| 3-6 | 0 | 125,000 | $0 | $2,932,200 | -$2,932,200 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 34,659 | 145,000 | $508,101 | $2,315,380 | -$1,807,279 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to PULSE BIOSCIENCES, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest Forms 3/4/5 holder
Robert W. Duggan
Net 12M change
+$8,555,859
Latest report
11 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Robert W. Duggan | Director, 10%+ Owner | $975,729,858 | +$13,508,089 | +1.4% | Mixed | 11 Jun 2026 |
| Mahkam Zanganeh | Director | $9,608,159 | Mixed | 11 Jun 2026 | ||
| Mitchell E. Levinson | Chief Strategy Officer | $1,544,213 | Mixed | 24 Sep 2024 | ||
| Darrin Uecker | Chief Technology Officer, Director | $1,137,624 | -$1,852,950 | -62% | Mixed | 23 Mar 2026 |
| Burke Thomas Barrett | Former President and CEO | $1,100,456 | Filing P/S | 11 Dec 2024 | ||
| Kevin Patrick Danahy | Chief Commercial Officer | $1,023,564 | -$3,394,630 | -77% | Filing P/S | 18 Feb 2026 |
| Ed Ebbers | EVP & GM, Dermatology | $359,595 | Mixed | 01 Jun 2021 | ||
| Paul A. Laviolette | Chief Executive Officer, Director | $312,007 | +$295,350 | +1773% | Filing P/S | 11 May 2026 |
| Laureen DeBuono | Director | Mixed | 04 Oct 2021 | |||
| Sandra A. Gardiner | CFO & EVP Admin. and Finance | Mixed | 14 Dec 2021 | |||
| Shelley D. Spray | Director | Mixed | 25 May 2023 | |||
| Kenneth A. Clark | Director | Mixed | 20 May 2021 | |||
| Manmeet Singh Soni | Director | Mixed | 11 Jun 2026 | |||
| Richard van den Broek | Director | Mixed | 11 Jun 2026 | |||
| Maria Sainz | Director | Mixed | 11 Jun 2026 | |||
| Steven Weber | Principal Accounting Officer | Mixed | 14 Jul 2025 |
Recent insider transactions for PULSE BIOSCIENCES, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mahkam Zanganeh | PLSE | Stock Option (right to buy) | Award | 44,504 | 30,000 | 11 Jun 2026 | Direct | |||
| Richard van den Broek | PLSE | Stock Option (right to buy) | Award | 38,423 | 30,000 | 11 Jun 2026 | Direct | |||
| Robert W. Duggan | PLSE | Stock Option (right to buy) | Award | 42,495 | 30,000 | 11 Jun 2026 | Direct | |||
| Manmeet Singh Soni | PLSE | Stock Option (right to buy) | Award | 30,000 | 30,000 | 11 Jun 2026 | Direct | |||
| Maria Sainz | PLSE | Stock Option (right to buy) | Award | 33,793 | 30,000 | 11 Jun 2026 | Direct | |||
| Robert W. Duggan | PLSE | Common Stock | Purchase | 1.38% | $12,999,988 | $19.69 | 660,233 | 48,370,047 | 11 May 2026 | Direct |
| Paul A. Laviolette | PLSE | Common Stock | Purchase | 1773% | $295,350 | $19.69 | 15,000 | 15,846 | 11 May 2026 | Direct |
| Darrin Uecker | PLSE | Restricted Stock Units | Award | 100,000 | 100,000 | 23 Mar 2026 | Direct | |||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -10.4% | $118,200 | $23.64 | -5,000 | 43,298 | 18 Feb 2026 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 11.6% | 5,000 | 48,298 | 18 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -1.64% | -5,000 | 300,000 | 18 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -31.6% | $472,600 | $23.63 | -20,000 | 43,298 | 17 Feb 2026 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 46.2% | 20,000 | 63,298 | 17 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -6.15% | -20,000 | 305,000 | 17 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -31.6% | $470,600 | $23.53 | -20,000 | 43,298 | 13 Feb 2026 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 46.2% | 20,000 | 63,298 | 13 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -5.8% | -20,000 | 325,000 | 13 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -31.6% | $467,400 | $23.37 | -20,000 | 43,298 | 12 Feb 2026 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 46.2% | 20,000 | 63,298 | 12 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -5.48% | -20,000 | 345,000 | 12 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -31.6% | $504,000 | $25.20 | -20,000 | 43,298 | 11 Feb 2026 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 46.2% | 20,000 | 63,298 | 11 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -5.19% | -20,000 | 365,000 | 11 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -31.6% | $470,400 | $23.52 | -20,000 | 43,298 | 10 Feb 2026 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 46.2% | 20,000 | 63,298 | 10 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -4.94% | -20,000 | 385,000 | 10 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -31.6% | $429,000 | $21.45 | -20,000 | 43,298 | 09 Feb 2026 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 46.2% | 20,000 | 63,298 | 09 Feb 2026 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -4.71% | -20,000 | 405,000 | 09 Feb 2026 | Direct | ||
| Maria Sainz | PLSE | Stock Option (right to buy) | Award | 3,104 | 3,104 | 05 Feb 2026 | Direct | |||
| Maria Sainz | PLSE | Stock Option (right to buy) | Award | 50,000 | 50,000 | 08 Jan 2026 | Direct | |||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -9.6% | $85,238 | $18.53 | -4,600 | 43,298 | 02 Oct 2025 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 10.6% | 4,600 | 47,898 | 02 Oct 2025 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -1.07% | -4,600 | 425,000 | 02 Oct 2025 | Direct | ||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -0.92% | $7,392 | $18.48 | -400 | 43,298 | 19 Sep 2025 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 0.92% | 400 | 43,698 | 19 Sep 2025 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -0.09% | -400 | 429,600 | 19 Sep 2025 | Direct | ||
| Kevin Patrick Danahy | PLSE | Common Stock | Sale | -31.6% | $369,800 | $18.49 | -20,000 | 43,298 | 18 Sep 2025 | Direct |
| Kevin Patrick Danahy | PLSE | Common Stock | Options Exercise | 46.2% | 20,000 | 63,298 | 18 Sep 2025 | Direct | ||
| Kevin Patrick Danahy | PLSE | Stock Option (right to buy) | Options Exercise | -4.44% | -20,000 | 430,000 | 18 Sep 2025 | Direct | ||
| Darrin Uecker | PLSE | Common Stock | Sale | -14% | $324,200 | $16.21 | -20,000 | 122,872 | 17 Sep 2025 | Direct |
| Darrin Uecker | PLSE | Common Stock | Options Exercise | 176.5% | 181,534 | 284,406 | 17 Sep 2025 | Direct | ||
| Darrin Uecker | PLSE | Stock Option (right to buy) | Options Exercise | -100% | -181,534 | 0 | 17 Sep 2025 | Direct | ||
| Darrin Uecker | PLSE | Common Stock | Sale | -16.9% | $407,000 | $16.28 | -25,000 | 122,872 | 16 Sep 2025 | Direct |
| Darrin Uecker | PLSE | Common Stock | Options Exercise | 20.4% | 25,000 | 147,872 | 16 Sep 2025 | Direct | ||
| Darrin Uecker | PLSE | Stock Option (right to buy) | Options Exercise | -23.5% | -25,000 | 81,534 | 16 Sep 2025 | Direct | ||
| Darrin Uecker | PLSE | Common Stock | Sale | -16.9% | $394,250 | $15.77 | -25,000 | 122,872 | 15 Sep 2025 | Direct |
| Darrin Uecker | PLSE | Common Stock | Options Exercise | 20.4% | 25,000 | 147,872 | 15 Sep 2025 | Direct | ||
| Darrin Uecker | PLSE | Stock Option (right to buy) | Options Exercise | -19% | -25,000 | 106,534 | 15 Sep 2025 | Direct | ||
| Darrin Uecker | PLSE | Common Stock | Sale | -16.9% | $358,000 | $14.32 | -25,000 | 122,872 | 12 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.